Literature DB >> 21659716

Cytomegalovirus: pathogen, paradigm, and puzzle.

Michael Boeckh1, Adam P Geballe.   

Abstract

Human cytomegalovirus (CMV), one of the eight herpesviruses that commonly infect humans, is best known for its propensity to cause disease in immunocompromised patients, especially transplant recipients, patients with advanced AIDS, and congenitally infected newborns. Advances in molecular virology coupled with improvements in diagnostic methods and treatment options have vastly improved our understanding of and ability to manage CMV, but many uncertainties remain, including the mechanisms of persistence and pathogenesis and its hypothesized roles in a variety of human illnesses. Here we review recent advances that are reshaping our view and approach to this fascinating virus.

Entities:  

Mesh:

Year:  2011        PMID: 21659716      PMCID: PMC3083799          DOI: 10.1172/JCI45449

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  116 in total

1.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors:  Dong Yu; Maria C Silva; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

Review 2.  Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?

Authors:  Garrett Lawlor; Alan C Moss
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

Review 3.  Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis.

Authors:  Pia Raanani; Anat Gafter-Gvili; Mical Paul; Isaac Ben-Bassat; Leonard Leibovici; Ofer Shpilberg
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

4.  Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.

Authors:  Scott M Palmer; Ajit P Limaye; Missy Banks; Dianne Gallup; Jeffrey Chapman; E Clinton Lawrence; Jordan Dunitz; Aaron Milstone; John Reynolds; Gordon L Yung; Kevin M Chan; Robert Aris; Edward Garrity; Vincent Valentine; Jonathan McCall; Shein-Chung Chow; Robert Duane Davis; Robin Avery
Journal:  Ann Intern Med       Date:  2010-06-15       Impact factor: 25.391

5.  Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

Authors:  D Lowance; H H Neumayer; C M Legendre; J P Squifflet; J Kovarik; P J Brennan; D Norman; R Mendez; M R Keating; G L Coggon; A Crisp; I C Lee
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

Review 6.  Antiviral drug resistance of human cytomegalovirus.

Authors:  Nell S Lurain; Sunwen Chou
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients.

Authors:  Margaret Pollack; Judson Heugel; Hu Xie; Wendy Leisenring; Jan Storek; Jo-Anne Young; Manisha Kukreja; Ronald Gress; Marcie Tomblyn; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

Review 8.  Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

Authors:  Michael Boeckh; W Garrett Nichols; Genovefa Papanicolaou; Robert Rubin; John R Wingard; John Zaia
Journal:  Biol Blood Marrow Transplant       Date:  2003-09       Impact factor: 5.742

9.  Incidence and sexual risk factors of cytomegalovirus seroconversion in HIV-infected subjects. The SEROCO Study Group.

Authors:  M Robain; N Carré; E Dussaix; D Salmon-Ceron; L Meyer
Journal:  Sex Transm Dis       Date:  1998-10       Impact factor: 2.830

Review 10.  Aspects of human cytomegalovirus latency and reactivation.

Authors:  M Reeves; J Sinclair
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

View more
  134 in total

Review 1.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  Enterocolitis with multiple ulcers of ileum and right colon in a patient with leukaemia attributed to cytomegalovirus.

Authors:  Iordanis N Papadopoulos; Ioanna Konstantiadou; Evaggelia Papantoni
Journal:  BMJ Case Rep       Date:  2012-05-30

3.  Histone H3 lysine 4 methylation marks postreplicative human cytomegalovirus chromatin.

Authors:  Alexandra Nitzsche; Charlotte Steinhäusser; Katrin Mücke; Christina Paulus; Michael Nevels
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 4.  The biology of cytomegalovirus drug resistance.

Authors:  Morgan Hakki; Sunwen Chou
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

5.  Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells.

Authors:  Farah Bughio; Mahadevaiah Umashankar; Jean Wilson; Felicia Goodrum
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

6.  Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography.

Authors:  Yoshie Kunihiro; Nobuyuki Tanaka; Reo Kawano; Toshiaki Yujiri; Makoto Kubo; Kazuhiro Ueda; Toshikazu Gondo; Taiga Kobayashi; Tsuneo Matsumoto
Journal:  Eur Radiol       Date:  2019-05-06       Impact factor: 5.315

7.  Detection of cytomegalovirus drug resistance mutations by next-generation sequencing.

Authors:  Malaya K Sahoo; Martina I Lefterova; Fumiko Yamamoto; Jesse J Waggoner; Sunwen Chou; Susan P Holmes; Matthew W Anderson; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

8.  Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.

Authors:  Mark R Schleiss; Craig J Bierle; Elizabeth C Swanson; Michael A McVoy; Jian Ben Wang; Zainab Al-Mahdi; Adam P Geballe
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

9.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

Review 10.  Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape.

Authors:  Santo Landolfo; Marco De Andrea; Valentina Dell'Oste; Francesca Gugliesi
Journal:  World J Virol       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.